- Report
- October 2024
- 192 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 380 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- May 2024
- 128 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- February 2021
- 420 Pages
United States
From €2047EUR$2,160USD£1,710GBP
€2275EUR$2,400USD£1,900GBP
- Report
- April 2023
- 165 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Lamotrigine is an anticonvulsant drug used to treat mental disorders such as bipolar disorder, depression, and schizophrenia. It is also used to treat seizures in adults and children. Lamotrigine works by stabilizing electrical activity in the brain, which helps to reduce the frequency and severity of seizures and mood swings. It is available in both generic and brand-name forms.
The Lamotrigine market is a competitive one, with many companies offering their own versions of the drug. It is widely prescribed by doctors and is generally well-tolerated by patients. Common side effects include dizziness, headache, nausea, and rash.
Companies in the Lamotrigine market include GlaxoSmithKline, Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more